RAC 0.66% $1.51 race oncology ltd

RAC media coverage, page-22

  1. 498 Posts.
    lightbulb Created with Sketch. 613
    RAC was mentioned by Stock head today:

    https://unauthorised investment advice/experts/scopos-powerplays-its-been-a-rollercoaster-ride-but-take-a-look-at-neuren/


    Race Oncology just keeps gaining

    Race Oncology (RAC) finished Thursday at $4.07, up 10.6 per cent for the week and more than tenfold (!) from a year ago, after announcing positive preclinical results for its lead drug candidate in treating breast cancer.

    Bisantrene was able to kill some cancer subtypes that resist currently used chemotherapeutic agents, according to the research conducted by University of Newcastle associate professor Nikki Verrills.

    Race Oncology said the results would be published in a high-impact scientific journal, and that it would update its clinical trial plans before the end of this quarter.

    Bisantrene was the subject of multiple clinical trials in the late 1980s and 1990s but then was essentially “lost” during a series of pharmaceutical mergers until RAC rediscovered it.

    Last edited by yannpiot: 13/03/21
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.51
Change
-0.010(0.66%)
Mkt cap ! $252.5M
Open High Low Value Volume
$1.55 $1.57 $1.47 $198.4K 131.1K

Buyers (Bids)

No. Vol. Price($)
1 19 $1.50
 

Sellers (Offers)

Price($) Vol. No.
$1.51 3154 3
View Market Depth
Last trade - 16.10pm 22/05/2024 (20 minute delay) ?
Last
$1.50
  Change
-0.010 ( 0.66 %)
Open High Low Volume
$1.53 $1.56 $1.47 18229
Last updated 15.53pm 22/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.